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Introduction 
• Myocardial bridging (MB) is a 
congenital anomaly in which a 
segment of a coronary artery 
takes a “tunneled” intramuscular 
course under a overlying 
myocardial “bridge” resulting in 
its systolic compression. 
• Most common localization for 
MB is middle segment of the left 
anterior descending coronary 
Myocardial bridge  
    artery (LAD). 
• Patients can be asymptomatic or present with myocardial 
ischemia, acute coronary syndromes, coronary spasm, exercise 
induced dysrhythmias, conduction abnormalities and sudden 
cardiac death. 
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Pathophysiology of MB 
• Myocardial perfusion occurs primarily in diastole, in normal conditions, 
only 15% of coronary blood flow occurs during systole. The degree of 
myocardial ischemia and resulting symptoms appear on first glance to 
be out of proportion to the degree of compromise in coronary blood 
flow by MB. 
• Tachycardia associated with increased sympathetic drive due to 
exercise or emotional distress can unmask the ischemic effect of MB. It 
reduces flow and myocardial perfusion by shortening diastolic 
perfusion time, and also increases coronary vasoconstriction as well as 
contraction of the MB over the tunneled artery. 
• Another factors contributing to myocardial ischemia are associated 
with the increasing left ventricular diastolic dysfunction associated 
with hypertension, and also with the coronary atherosclerosis which 
usually spares the MB itself and appears proximally from tunneled 
artery over the course of time. 
 
 
Types of myocardial bridges 
There are several types of myocardial bridges based on the depth 
and the length of the MB: Potentially symptomatic MB 
Pathophysiology of MB 
Factors which define hemodynamic impact, clinical 
presentation and outcomes in patients with MB 
Symptoms and signs of MM 
Up to one-third of patients with a myocardial bridge do not have 
any symptoms.  
In symptomatic patients clinical manifestations are most likely 
caused by the myocardial ischemia and may include:  
• chest pain,  
• Tightness or heaviness in the chest, associated with the pain in 
the left arm or jaw, 
• shortness of breath,  
• fatigue  
Symptoms usually do not develop before the third decade; the 
reason for this is not clear. 
 
 
Diagnosis of MM 
Diagnostic tests include: 
• Coronary angiography  
• Intracoronary Doppler 
• Intravascular ultrasound 
• Fractional flow reserve Cardiac computed tomography (CT) 
angiography 
Angiography in MB 
• Typical systolic compression (arrows) of the mid LAD at two sites in 
series. Diastolic lumen dimensions are normal. The coronary tree 
shows no angiographic signs of coronary atherosclerosis. 
https://www.ahajournals.org/doi/epub/10.1161/01.CIR.0000038420.14867.7A 
Treatment strategy of MB 
MB without  symptoms 
No symptoms 
Improvement 
•Relieve potential triggers; 
•Risk factors modifications; 
•Antiplatelet therapy in case 
of atherosclerosis; 
Follow-up 
• β-blockers/calcium channel blockers 
• Consider ivabradine together with 
lower dose of β-blockers/calcium channel 
blockers 
• Avoid nitrates  
• Relieve potential triggers 
• Risk factors modification 
• Antiplatelet therapy in case of 
atherosclerosis 
MB with symptoms and signs of ischemia 




NB! Nitrates worsen symptoms due 
to the increased systolic 
compression of the tunneled artery 
Supra-arterial myotomy 
• Supra-arterial myotomy involves 
resection of the overlying muscle 
fibers resulting in elimination of 
the symptoms and increase in the 
coronary flow.  
• The procedure is used in patients 
with refractory symptoms despite 
medical therapy, especially in 
those with demonstrated inducible 
ischemia and those who 
      are at high risk for myocardial infarction, ventricular tachycardia, or 
resuscitated cardiac arrest.  
• Surgical risks include dissection into the ventricle in patients with 





• Coronary artery bypass graft 
(CABG) surgery in treatment of MB 
typically involves anastomosis of 
the left internal mammary artery to 
the LAD artery.  
• CABG can be considered a 
treatment option for myocardial 
bridging, especially in extensive 




• Name: B. O. P. 
•  Sex: male 
•  Age: 50 years 
•  Location: Kharkiv 
•  Occupation: not working (disability II degree). 
Complaints 
• Dyspnea on moderate physical exertion (on walking up to 300 m) 
• Periodical pressing chest pain with duration of 3-5 minutes with 
irradiation to the left arm, shoulder blade on physical exertion 
(walking or climbing stairs rapidly) relieved by rest 
• General weakness, malaise 
 
Anamnesis morbi 
• Since 2013 had periodical chest discomfort relieved by rest which 
appeared without apparent reason, the patient didn’t seek for medical 
help. 19.07.2014 while playing basketball on vacation first appeared 
intense chest pain not relieved by rest.  
• The patient was urgently hospitalized to Primorsk hospital where the 
diagnosis of antero-lateral ST elevation myocardial infarcion (STEMI) 
was made. Angiography and percutaneous coronary intervention (PCI) 
were not performed due to absence of such capacities. The patient 
was treated with thrombolytics (streptokinase). Acute period of the 
disease was complicated with acute heart failure (treated with 
levosimendan) and formation of an aneurism of an apex of left 
ventricle. 
• 14.08.14 was transferred for the rehabilitation  to the Kharkiv hospital 
#8 where angiography was performed which showed the presence of 
myocardial bridge of anterior descending artery occluding its lumen by 
80% in systole.  
Anamnesis morbi-2 
• Was recommended surgical treatment and the patient was 
referred to the Kyiv heart center where the coronary artery 
bypass grafting procedure (CABG) was performed (31.10.14). 
Postoperative period passed without complications. With the 
improvement of his condition was discharged under supervision 
of cardiologist.  
• Annually had planned hospitalization. Since 2020 periodically 
experienced chest discomfort 1-2 times in a month, treated with 
beta-blockers under control of HR and ECG. 
• Last hospitalization in November 2020 due to worsening of his 
condition which started 1 month ago with an increased dyspnea, 






• Not working (until 2014 worked as a school teacher). 
• Postponed diseases: URVI, chicken pox in childhood. 
• Tuberculosis, diabetes, viral hepatitis, allergic reactions denies. 
• Bad habits denies.  
• Hereditary history is not burdened. 
• According to the patient there were no cardiovascular diseases 
in the family  







• General condition is relatively satisfactory, clear consciousness, 
posture is active, patient is normosthenic. 
• Weight -  85 kg, height – 178 cm. BMI – 26,8 kg/m2; t - 36.7°C. 
• Skin and visible mucosae - pink, clean with preserved moistness; 
subcutaneous adipose tissue - developed moderately, distributed 
symmetrically. Lymphatic nodes are not palpable. No peripheral edemas. 
• Thyroid gland is not enlarged; 
• Lungs: resonant percussion sound, on auscultation – prolonged 
exhalation, RR -19/’; 
• Heart borders extend 1,5 cm to the left , heart sounds are clear, 
rhythmic, muffled. HR=pulse=68 bpm. Pulse is rhythmic. BP dex=128/80, 
BP sin=125/80. 
• On palpation abdomen is painless, liver does not protrude from costal 





Plan of investigations 
• Full blood count, urinalysis 
• Biochemical panel (lipid profile, fasting plasma glucose,  AST, 
ALT, albumin, creatinine, total protein, calcium, potassium, 
sodium, chlorides, coagulogram) 
• Resting ECG 
• Exercise ECG test 
• Holter monitoring 
• EchoCG 
• Chest X-ray 
• Coronary angiography – patient refused from the procedure 
 
Full blood count 
Conclusion: leucocytosis, increased ESR, eosinophilia 
 
Options Results Normal range 
Hemoglobin, g/L 147 130,0 – 160,0 
Erythrocytes × 𝟏𝟎𝟏𝟐/l 4,4 4,0- 5,0 
Leukocytes × 𝟏𝟎𝟗/L 6,1 4,0 – 9,0 
ESR, mm/h 5 2-15 
Stab neutrophils, % 1 1-6 
Segmented neutrophils, % 58 47-72 
Eosinophils, % 3 0,5-5,0 
Basophils, % 0 1-1,0 
Lymphocytes, % 32 19-37 
Monocytes, % 6 3-11 
Conclusion: without pathological changes,  
Urine analysis 
Options Results Normal range 
Specific gravity   1,013 1,001-1,040 
pH 6,0 5,0-7,0 
Protein, g / l Not detected to 0.033 
Glucose  Not detected absent 
Leucocytes, cells/hpf 1-3 6-8 
Epithelium, cells/hpf 1-2 ≤15-20 
Bacteria  Not detected absent 
Conclusion: all parameters within the normal range 
Biochemical panel 
Options Results Normal range 
Total protein, g/l 70 54-78 
Urea, mmol/l 6,7 1,7-8,3 
Creatinine, mmol/l 0,93 0,7-1,4  
AST, U 28 <41  
ALT, U 27 <40  
FPG (fasting plasma glucose), 
mmol/l 
4,9 3,3-5,5 
K, mmol/l 4,97 3,5-5,1 
Са, mmol/l 2,25 2,15-2,57 
Na, mmol/l 144 136-146 
Cl, mmol/l 104 98–106  
Conclusion: all parameters within the normal range 
Coagulogram 
Parameters Result Normal range  
Bleeding time(by Lee-
White methods), min 
4,0 5-10 min 
Platelets number 186 180-320 
APTT (sec) 33 27-36 
Time of plasma 
recalcification, sec 
87 120-60 
Prothrombin index, % 94 80-110 
Fibrinogen, g/l 2,6 2-4  
Conclusion: all parameters within the normal range 
Lipid profile 
• Conclusion: increased levels of VLDL and triglycerides 
Options Results Normal range 
Total cholesterol, mmol/l 4,22 3,0-5,2 
Very low-density lipoprotein 
cholesterol (VLDL-C), mmol/l 
1,7 <0,88 
Low-density lipoprotein 
cholesterol (LDL-С) ), mmol/l 
1,46 <3,5 
High-density lipoprotein 
cholesterol (HDL-C) ), mmol/l 
1,06 >0,9 
Triglycerides), mmol/l 3,74 <1,7 
Atherogenic coefficient 2,98 <3,0 
ECG 
• Conclusion: HR- 
67 bpm, sinus 
regular rhythm, 




lateral leads and 
apical aneurism 
• (pathological Q 
wave in leads I,  
aVL, V2-V5, ST 
elevation in 
leads V2-V5, T 
wave inversion 




• Holter monitoring: sinus rhythm, average HR during the daytime – 75 
bpm, during night – 66 bpm, sinus pauses were not detected, during 24 
hours were detected 3 PAC and 15 unifocal PVC on the background of 
postinfarctional cardiosclerotic changes and ST segment deviation of 1 
mm. 
• EchoCG: hypokinesia of antero-septal segments of left ventricle, 
akinesia of left ventricular apex – echocardiographic signs of 
postinfarctional aneurism, dilation of the left sided chambers (left 
atrium -5,1cm, left ventricle end-diastolic diameter -6,3cm), left 
ventricular hypertrophy, systolic dysfunction of left ventricle (reduced 
ejection fraction-39%). 
• Chest X-ray: increased width of the cardiac silhoette, the lungs without 
focal pulmonary consolidation or pleural effusion. 
• Treadmil test – total load 7.0 MET, performed the load for 6 minutes, the 
test was terminated due to the onset of pain and 1 mm ST depression 
in leads V4-V6, moderate limitation in the level of the threshold load, 




pronounced left type of 
coronary blood supply. Left 
coronary artery trunk – 
without pathology, anterior 
descending artery - 
"muscular bridge", 
occluding the artery lumen 
by 80% in systole, the 
circumflex right coronary 
artery without significant 
hemodynamic disorders. 
Diagnosis 
Main diagnosis: Ischemic heart disease: stable angina II FC, 
postinfarctional cardiosclerosis (antero-lateral STEMI 20.07.2014) 
in the presence of myocardial bridge (coronary angiography 
14.08.14). Postinfarctional aneurism. CABG surgery (31.10.2014). 
Chronic heart failure IIC with reduced EF (39%). 
 
Treatment 
• Life style modification: diet with restriction of satured fat; 
• Bisoprolol 5 mg once daily under control of HR and ECG; 
• Eplerenone 25 mg once daily; 
• Rozuvastatin 20 mg once daily under the control of lipid profile 
and LFTs; 
• Ramipril 1,25 mg once daily; 
• Aspirin 100 mg once daily; 
• Quercetin 2g twice daily 1 month. 
Recommendations: coronary angiography is recommended in 
order to detect exacerbation of the disease and possible 






• The myocardial bridge is often a benign pathology with an 
asymptomatic course of the disease. However, in some cases 
MB is associated with myocardial ischemia, ACS, life-
threatening arrhythmias, and sudden death.  
• Patients with symptomatic MB as in our clinical case require 
early diagnosis with adequate and timely therapy and dynamic 
monitoring with the help of coronary angiography and other 
visualization methods of investigation in order to detect disease 
exacerbation and prevent further complications which may be 
associated with MB. 
 
Thank you for your attention! 
Any questions? 
